Performing synthetic worlds: Situating the bioeconomy

Science and Public Policy

Volumn 40, Issue 4, 2013, Pages 453-465

  Kearnes, Matthew ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bioeconomy; Hybrid forum; Performativity; Science policy; Spatiality; Synthetic biology

Indexed keywords

ACTOR NETWORK THEORY; BIOTECHNOLOGY; CONCEPTUAL FRAMEWORK; MANAGEMENT PRACTICE; ORGANIZATIONAL FRAMEWORK; RESEARCH AND DEVELOPMENT; SCIENCE AND TECHNOLOGY;

UNITED KINGDOM;

EID: 84884915760     PISSN: 03023427     EISSN: None     Source Type: Journal    
DOI: 10.1093/scipol/sct052     Document Type: Article

References (65)

1. Anon (2009) Tender Documentation - Prequalification Questionaire, Contract for Public Dialogue on the Science, Social & Ethical Issues of Synthetic Biology. Swindon, UK: Shared Services Centre, Research Councils UK.
2. Anon (2013) What are the aims of the SBLC?, https://connectinnovateuk.org/web/synthetic-biology-special-interestgroup/39 accessed 18 April 2013.
3. Austin, J. L. (1962) How to do Things With Words. Oxford, UK: OUP.
4. Austin, R. et al. (2007) The Ilulissat Statement: Synthesising the Future: A Vision for the Convergence of Synthetic Biology and Nanotechnology. Ilulissat, Greenland: Kavli Foundation.
5. Balmer, A. and Martin, P. (2008) Synthetic Biology: Social and Ethical Challenges. Nottingham, UK: Institute for Science and Society, University of Nottingham.
6. Barben, D., Fisher, E., Selin, C. and Guston, D. (2008) 'Anticapatory governance of nanotechnology: Foresight, engagement and integration'. In: Hackett, E. J., Amsterdamska, O., Lynch, M. and Wajcman, J. (eds) The Handbook of Science and Technology Studies, 3rd edn, pp. 979-1000. Cambridge, MA: MIT Press.
7. Bhattachary, D. (2010) Synthetic Biology Dialogue. Swindon, UK: EPSRC/BBSRC.
8. Birch, K. (2007) 'The virtual bioeconomy: the "failure" of performativity and the implications for bioeconomics', Distinktion: Scandinavian Journal of Social Theory, 8: 83-99.
9. Birch, K. (2009) 'The knowledge-space dynamic in the UK bioeconomy', Area, 41: 273-84.
10. Birch, K., Levidow, L. and Papaioannou, T. (2012) 'Self-fulfilling prophecies of the European knowledge-based bio-economy: The discursive shaping of institutional and policy frameworks in the bio-pharmaceuticals sector', Journal of the Knowledge Economy, DOI 10.1007/s13132-012-0117-4.
11. Borup, M., Brown, N., Konrad, K. and van Lente, H. (2006) 'The sociology of expectations in science and technology', Technology Analysis and Strategic Management, 18: 285-98.
12. Brown, N. and Michael, M. (2003) 'A sociology of expectations: Retrospecting prospects and prospecting retrospects', Technology Analysis and Strategic Management, 15: 4-18.
13. Bush, V. (1945) Science the Endless Frontier. Washington, DC: US Government Printing Office.
14. Ç alişkan, K. and Callon, M. (2009) 'Economization, part 1: Shifting attention from the economy towards processes of economization', Economy and Society, 38: 369-98.
15. Callon, M. (1991) 'Techno-economic networks and irreversibility'. In: Law, J. (ed.) A Sociology of Monsters: Essays on Power, Technology and Domination, pp. 132-161. London: Routledge.
16. Callon, M. (2007) 'What does it mean to say that economics is performative'. In: MacKenzie, D., Muniesa, F. and Siu, L. (eds) Do Economists Make Markets: On the Peformativity of Economics, pp. 311-57. Princeton, NJ: Princeton University Press.
17. Callon, M., Méadel, C. and Rabeharisoa, V. (2002) 'The economy of qualities', Economy and Society, 31: 194-217.
18. Callon, M. and Muniesa, F. (2005) 'Economic markets as calculative collective devices', Organisation Studies, 26: 1229-50.
19. Callon, M. and Rip, A. (1992) 'Humains, non-humains: morale d'une coexistence'. In: Theys, J. and Kalaora, B. (eds) La Terre Outragée: Les Experts Sont Formels, pp. 140-56. Paris: Editions Autrement.
20. Calvert, J. (2012) 'Ownership and sharing in synthetic biology: A 'diverse ecology' of the open and the proprietary?', BioSocieties, 7: 169-87.
21. Calvert, J. and Martin, P. (2009) 'The role of social scientists in synthetic biology', EMBO Reports, 10/3: 201-4.
22. Campos, L. (2010) 'That was the synthetic biology that was'. In: Schmidt, M., Kelle, A., Ganguli-Mitra, A. and de Vriend, H. (eds) Synthetic Biology: The Technoscience and its Social Consequences, pp. 5-21. Dordecht, the Netherlands: Springer.
23. Carlson, R. (2001) 'Open source biology and its impact on industry', IEEE Spectrum, 38/5: 15-7.
24. Carlson, R. (2010) Biology is Technology: The Promise, Peril and New Business of Engineering Life. Cambridge, MA: Harvard University Press.
25. Carlson, R. and Brent, R. (2000) Letter to DARPA on Open Source Biology, http://www.synthesis.cc/DARPA_OSB_Letter.pdf accessed 25 August 2012.
26. Cooper, M. (2008) Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era. Seattle, WA: University of Washington Press.
27. Davenport, S., Leitch, S. and Rip, A. (2003) 'The "user" in research funding negotiation processes', Science and Public Policy, 30: 239-50.
28. European Commission (2005) Synthetic Biology: Applying Engineering to Biology: A Report of a NEST High-Level Expert Group. Brussels: European Commission.
29. European Commission (2012) Innovating for Sustainable Growth: A Bioeconomy for Europe COM(2012) 60. Brussels: European Commission. Gregory, D. J. (1994) Geographical Imaginations. Oxford, UK: Blackwell.
30. Hart, D. M. (1998) Forged Consensus: Science, Technology and Economic Policy in the United States, 1921-1953. Princeton, NJ: Princeton University Press.
31. High Level Group (2004) Facing the Challenge. The Lisbon Strategy for Growth and Employment. Report from the High Level Group chaired by Wim Kok Office. Luxembourg: Official Publications of the European Communities.
32. Keller, E. F. (2009) 'What does synthetic biology have to do with biology?', BioSocieties, 4: 291-302.
33. Kleinman, D. L. (1995) Politics on the Endless Frontier: Postwar Research Policy in the United States. Durham, NC: Duke University Press.
34. Klerkz, L. and Leeuwins, C. (2008) 'Delegation of authority in research funding to networks: Experiences with a multiple goal boundary organization', Science and Public Policy, 35: 183-96.
35. Kuhlmann, S. (2007) 'Governance of innovation: Practice, policy and theory as dancing partners'. Text of an address delivered upon the acceptance of the Chair Foundations of Science, Technology and Society Faculty Management and Governance, University of Twente, 4 October 2007.
36. Leduc, S. (1912) La Biologie Synthétique. Paris: A. Poinot.
37. Lezaun, J. (2007) 'A market of opinions: The political epistemology of focus groups', Sociological Review, 55(S2): 130-51.
38. Lux Research (2009) Synthetic Biology's Commercial Roadmap. New York: Lux Research Inc.
39. Macnaghten, M. (2010) 'Researching technoscientific concerns in-the-making: Narrative structures, public responses and emerging nanotechnologies', Environment and Planning A, 42: 23-37.
40. Macnaghten, P. M., Kearnes, M. B. and Wynne, B. (2005) 'Nanotechnology, governance and public deliberation: What role for the social sciences?', Science Communication, 27: 268-87.
41. Miller, D. (2003) 'The virtual moment', Journal of the Royal Anthropological Institute, 9: 57-75.
42. Molyneux-Hodgson, S. and Meyer, M. (2009) 'Tales of emergence- synthetic biology as a scientific community in the making', BioSocieties, 4: 129-45.
43. Nightingale, P. and Martin, P. (2004) 'The myth of the biotech revolution', Trends in Biotechnology, 22: 564-9.
44. Nordmann, A. (2004) Converging Technologies - Shaping the Future of European Societies. Brussels: European Commission.
45. OECD (2006) The Bioeconomy to 2030: Designing a Policy Agenda. Paris: OECD.
46. OECD (2009) The Bioeconomy to 2030: Designing a Policy Agenda. Paris: OECD.
47. Pollock, N. and Williams, R. (2010) 'The business of expectations: How promissory organizations shape technology and innovation', Social Studies of Science, 40: 525-48.
48. Rabinow, P. (2009) 'Prosperity, amelioration, flourishing: From a logic of practical judgement to reconstruction', Law and Literature, 21: 301-20.
49. Rabinow, P. and Bennett, G. (2012) Designing Human Practices: An Experiment with Synthetic Biology. Chicago: University of Chicago Press.
50. Roco, M. and Bainbridge, W. S. (eds) (2002) Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and the Cognitive Science. Arlington, VA: National Science Foundation. Royal Academy of Engineering. (2009a) Synthetic Biology: Public Dialogue on Synthetic Biology. London: Royal Academy of Engineering.
51. Royal Academy of Engineering (2009b) Synthetic Biology: Scope, Applications and Implications. London: Royal Academy of Engineering.
52. Sunder Rajan, K. (2006) Biocapital: The Constitution of Postgenomic Life. Durham, NC: Duke University Press.
53. Synthetic Biology Oversight Group (2009) Minutes of the 15 BBSRC/EPSRC Synthetic Biology Oversight Group Meeting held 1 December 2009. Swindon, BBSRC, www. bbsrc.ac.uk/web/FILES/Meetings/0912-synthetic-biology-ogminutes. pdf accessed 8 May 2013.
54. Synthetic Biology Oversight Group (2010) Minutes of the BBSRC/EPSRC Synthetic Biology Oversight Group Meeting held 3 February 2010. Swindon, BBSRC. www.bbsrc.ac.uk/web/FILES/Meetings/1002-synthetic-biology-og-minutes.pdf accessed 8 May 2013.
55. The White House (2012) National Bioeconomy Blueprint. Washington, DC: The White House.
56. Thorpe, C. and Gregory, J. (2010) 'Producing the post-Fordist public: The political economy of public engagement with science', Science as Culture, 19: 273-301.
57. TNS-BMRB (2009a) Synethtic Biology: Actors Script. London: TNS-BMRB.
58. TNS-BMRB (2009b) Synthetic Biology: Stimulus Material. London: TNS-BMRB.
59. TNS-BMRB (2010) BBSRC and EPSRC Synthetic Biology Public Dialogues, TNS-BMRB Methodology. London: TNSBMRM.
60. UK Synthetic Biology Roadmap Coordination Group. (2012) A Synthetic Biology Roadmap for the UK. Swindon, UK: Technology Strategy Board.
61. Vinck, D. (2010) The Sociology of Scientific Work: The Fundamental Relationship Between Science and Society. Cheltenham, UK: Edward Elgar.
62. Waldby, C. (2002) 'Stem cells, tissue cultures and the production of biovalue', Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 6: 305-23.
63. Waldby, C. (2009) 'Singapore biopolis: Bare life in the city-state', East Asian Science, Technology and Society, 3: 367-83.
64. Willetts, D. (2012) Response to A Synthetic Biology Roadmap for the UK, Open letter to Dr Lionel Clarke, Global Strategic Programme Manager, Innovation-Biodomain Technology Group, Shell Global Solutions (UK), 3 November 2012. London, Department for Business, Innovation and Skills. London, Department for Business, Innovation and Skills, www.bis.gov.uk/assets/biscore/science/docs/r/12-1250-response-to-synthetic-biology-roadmap-for-uk accessed 3 November 2012.
65. Wynne, B. (2006) 'Public engagement as a means of restoring public trust in science: Hitting the notes, but missing the music?', Community Genetics, 9: 211-20.